Gabriela Gruia
Director/Board Member at TSCAN THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Profile
Gabriela Gruia is the founder of Dr. Gruia Consulting LLC, which was founded in 2021.
She is currently working as the Principal at Dr. Gruia Consulting LLC.
Additionally, Dr. Gruia holds current positions as an Independent Director at Molecular Templates, Inc., TScan Therapeutics, Inc., Aprea Therapeutics, Inc., and Tessa Therapeutics Ltd.
She started her role as an Independent Director at Molecular Templates, Inc. in 2022, at TScan Therapeutics, Inc. in 2021, at Aprea Therapeutics, Inc. in 2023, and at Tessa Therapeutics Ltd in 2021.
Previously, Dr. Gruia worked at Novartis Oncology, Inc. from 2004 to 2020 as the SVP & Head-Global Regulatory Affairs.
She also worked at Ichnos Sciences, Inc. from 2020 to 2021 as the Chief Development Officer.
Dr. Gruia obtained a doctorate degree from Medicine & Pharmacy Carol Davila University of.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-07 | 0 ( -.--% ) | - $ | 2024-05-30 | |
TSCAN THERAPEUTICS, INC.
-.--% | 2024-03-30 | 0 ( -.--% ) | - $ | 2024-05-30 |
APREA THERAPEUTICS, INC.
-.--% | 2024-04-22 | 0 ( -.--% ) | - $ | 2024-05-30 |
Gabriela Gruia active positions
| Companies | Position | Start |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director/Board Member | 2021-05-26 |
| MOLECULAR TEMPLATES, INC. | Director/Board Member | 2022-02-28 |
| APREA THERAPEUTICS, INC. | Director/Board Member | 2023-05-04 |
| Gabriela Gruia Consulting LLC | Founder | 2020-12-31 |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Director/Board Member | 2020-12-31 |
Former positions of Gabriela Gruia
| Companies | Position | End |
|---|---|---|
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Corporate Officer/Principal | 2020-12-31 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2020-01-31 |
Training of Gabriela Gruia
| Medicine & Pharmacy Carol Davila University of | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| MOLECULAR TEMPLATES, INC. | Health Technology |
| APREA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Commercial Services |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
| Gabriela Gruia Consulting LLC | |
Tessa Therapeutics Ltd
Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Health Technology |
- Stock Market
- Insiders
- Gabriela Gruia
